Latest Metformin Stories
A new study, published Sunday in the New England Journal of Medicine (NEJM), reveals that a combination treatment may be the best way to treat type 2 diabetes in children and adolescents.
An international team of scientists has discovered a link between the active ingredient in aspirin and a protein which helps regulate cell growth and metabolism -- a link which could mean that the same anti-inflammatory medication and pain reliever might potentially be able to help treat cancer and prevent Type 2 Diabetes.
Patients suffering from type 2 diabetes may not benefit from taking both an oral glucose lowering drug (metformin) and insulin instead of insulin alone.
A major 12-year study based on a Taiwanese population cohort has demonstrated that not only does diabetes increase the risk of developing Parkinson's disease more than 2-fold, the use of sulfonylureas, commonly used as treatment for diabetes, increases the risk further by about 57%.
Although the drug metformin is considered the gold standard in the management of type 2 diabetes, a study by a group of French researchers published in this week's PLoS Medicine suggests that the long-term benefits of this drug compared with the risks are not clearly established—an important finding given that currently, thousands of people around the world are regularly taking metformin to help control their blood sugar levels in the belief that it also has long-lasting health benefits.
A new study shows that men with prostate cancer may be able to reduce the growth rate of cancer with the help of a commonly prescribed diabetes medication known as metformin.
The use of metformin in men with prostate cancer before prostatectomy helped to reduce certain metabolic parameters and slow the growth rate of the cancer.
Metformin, a drug widely used to treat Type II diabetes, may help to prevent primary liver cancer.
The widely used diabetes medicine metformin can have protective effects on the heart.